GlassScriptPhysician profile
Aayushman Misra
NPI 1083926067
$781.03
in general payments reported to CMS, 2019-2025
9 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.40 · 2020: $22.28 · 2021: $160 · 2022: $14.52 · 2024: $144 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $196.73 | 2025 | |
| Cardiovascular Systems INC. | $160.28 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $118.84 | 2019-2024 | Eliquis |
| Amgen INC. | $65.59 | 2024-2025 | Repatha, Repatha |
| Abiomed | $61.93 | 2024 | Impella |
| Janssen Pharmaceuticals, INC | $58.35 | 2020-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $58.11 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.74 | 2025 | Lifevest |
| Ceribell, INC. | $23.46 | 2025 | Pocket Eeg Device |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aayushman Misra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.